Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range

Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range

The aim of the study was to evaluate the anti - Xa - activity (aXa) of selective and non - selective factor Xa inhibitors in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) patients according to clinical implications and laboratory parameters. Materials and metho...

Full description

Bibliographic Details
Main Authors:	N V Seredavkina, T M Reshetnyak, M A Satybaldyeva, L N Kashnikova, T A Temnikova, E L Nasonov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2019-05-01
Series:	Терапевтический архив
Subjects:	anti-xa-activity low weight molecular heparins systemic lupus erythematosus antiphospholipid syndrome
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/33571/pdf

Similar Items

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: D V Reshetnyak, et al.
Published: (2004-05-01)

Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
by: Tatiana Reshetnyak, et al.
Published: (2023-05-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
by: Tatiana Reshetnyak, et al.
Published: (2022-08-01)

Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
by: Creso Abreu Falcão, et al.
Published: (2002-09-01)

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01)

Primary antiphospholipid syndrome progressing to systemic lupus erythematosus: a case report
by: Rocco Manganelli, et al.
Published: (2013-04-01)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
by: Ryo Hisada, et al.
Published: (2023-03-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
by: I. E. Shirokova, et al.
Published: (2003-08-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
by: I. A. Doroshkevich, et al.
Published: (2004-06-01)

Secondary antiphospholipid syndrome in systemic lupus erythematosus – screening, diagnosis and treatment methods
by: Andrei-Bogdan Mihailescu, et al.
Published: (2022-06-01)

Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future
by: Evgeny L. Nasonov, et al.
Published: (2023-07-01)

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01)

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01)

Anesthetic management of patient with systemic lupus erythematosus and antiphospholipid antibodies syndrome for laparoscopic nephrectomy and cholecystectomy
by: Rashid Saeed Khokhar, et al.
Published: (2015-01-01)

Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome
by: Yousef Mohammadi Kebar, et al.
Published: (2019-06-01)

Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study
by: Carolien N. H. Abheiden, et al.
Published: (2017-01-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

Splenic infarcts in a lady with systemic lupus erythematosus and negative antiphospholipid antibodies—A rare case report
by: Amr Ashour, et al.
Published: (2023-03-01)

Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
by: Tatiana M. Reshetnyak, et al.
Published: (2022-06-01)

Changes in Clinical Manifestations and Course of Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome over Three Decades
by: Nikolett Nagy, et al.
Published: (2023-04-01)

Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies
by: Chiara Schiavi, et al.
Published: (2023-11-01)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
by: Signe Risbøl Vils, et al.
Published: (2023-04-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
by: N V Seredavkina, et al.
Published: (2009-08-01)

Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)

The anti-factor Xa range for low molecular weight heparin thromboprophylaxis
by: Matthew Y. Wei, et al.
Published: (2015-11-01)

A rare combination of autoimmune hemolytic anemia and primary antiphospholipid syndrome evolving into systemic lupus erythematosus
by: Swarupa Nikhil Bhagwat, et al.
Published: (2016-01-01)

Thrombolytic Therapy for Cerebral Vein Thrombosis in Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
by: Mehrzad Hajialilo, et al.
Published: (2012-03-01)

Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
by: Lina Wirestam, et al.
Published: (2019-11-01)

Myocardial damage and affection of coronary arteries of the heart in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N N Bazhanov, et al.
Published: (2004-05-01)

Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
by: Núria Baños, et al.
Published: (2022-11-01)

Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus
by: S Iu Serikova, et al.
Published: (2008-06-01)

Budd–Chiari Syndrome as an Initial Presentation of Systemic Lupus Erythematosus Associated with Antiphospholipid Syndrome: A Case Report with Review of the Literature
by: Solela G, et al.
Published: (2023-08-01)

Pediatric antiphospholipid syndrome
by: Petrović Gordana, et al.
Published: (2023-01-01)

Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome
by: G A Movsisyan, et al.
Published: (2017-09-01)

Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus
by: E N Borisov, et al.
Published: (2014-06-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

Antiphospholipid syndrome
by: Pavlović Dragan M., et al.
Published: (2010-01-01)